Investors in Chorus Limited (NZSE:CNU) had a good week, as its shares rose 6.1% to close at NZ$8.65 following the release of its annual results. Revenues came in at NZ$1.0b, in line with estimates, while Chorus reported a statutory loss of NZ$0.02 per share, well short of prior analyst forecasts for a profit. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

See our latest analysis for Chorus  earnings-and-revenue-growth

Following last week's earnings report, Chorus' seven analysts are forecasting 2025 revenues to be NZ$1.03b, approximately in line with the last 12 months. Earnings are expected to improve, with Chorus forecast to report a statutory profit of NZ$0.063 per share. Before this earnings report, the analysts had been forecasting revenues of NZ$1.02b and earnings per share (EPS) of NZ$0.067 in 2025. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

Despite cutting their earnings forecasts,the analysts have lifted their price target 5.4% to NZ$7.78, suggesting that these impacts are not expected to weigh on the stock's value in the long term. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Chorus, with the most bullish analyst valuing it at NZ$8.40 and the most bearish at NZ$5.32 per share. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Chorus shareholders.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting Chorus' growth to accelerate, with the forecast 1.7% annualised growth to the end of 2025 ranking favourably alongside historical growth of 0.8% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 3.4% per year. So it's clear that despite the acceleration in growth, Chorus is expected to grow meaningfully slower than the industry average.



The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Chorus going out to 2027, and you can see them free on our platform here..

You should always think about risks though. Case in point, we've spotted  2 warning signs for Chorus you should be aware of.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.